Mantra Pharma Inc recorded insider activity on July 21, 2025, when Director Raj Chowdhry purchased 300,000 shares valued at 30,000 dollars. Previous acquisitions by Rajinder Chowdhry occurred during 2022. These historical filings represent the most recent documented transactions for the organization.